Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Soleno Therapeutics stock | $0.76

Learn how to easily invest in Soleno Therapeutics stock.

Soleno Therapeutics Inc is a biotechnology business based in the US. Soleno Therapeutics shares (SLNO) are listed on the NASDAQ and all prices are listed in US Dollars. Soleno Therapeutics employs 17 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Soleno Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SLNO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Soleno Therapeutics stock price (NASDAQ: SLNO)

Use our graph to track the performance of SLNO stocks over time.

Soleno Therapeutics shares at a glance

Information last updated 2021-10-24.
Latest market close$0.76
52-week range$0.75 - $3.36
50-day moving average $0.87
200-day moving average $1.00
Wall St. target price$6.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.39

Buy Soleno Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Soleno Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Soleno Therapeutics price performance over time

Historical closes compared with the close of $0.76 from 2021-10-27

1 week (2021-10-21) -1.30%
1 month (2021-09-28) -20.34%
3 months (2021-07-28) -17.48%
6 months (2021-04-28) -39.20%
1 year (2020-10-28) -53.09%
2 years (2019-10-28) -45.71%
3 years (2018-10-26) 2
5 years (2016-10-28) 1.03

Soleno Therapeutics financials

Gross profit TTM $0
Return on assets TTM -32.41%
Return on equity TTM -74.96%
Profit margin 0%
Book value $0.34
Market capitalisation $61.8 million

TTM: trailing 12 months

Shorting Soleno Therapeutics shares

There are currently 1.3 million Soleno Therapeutics shares held short by investors – that's known as Soleno Therapeutics's "short interest". This figure is 11% down from 1.5 million last month.

There are a few different ways that this level of interest in shorting Soleno Therapeutics shares can be evaluated.

Soleno Therapeutics's "short interest ratio" (SIR)

Soleno Therapeutics's "short interest ratio" (SIR) is the quantity of Soleno Therapeutics shares currently shorted divided by the average quantity of Soleno Therapeutics shares traded daily (recently around 488234.45692884). Soleno Therapeutics's SIR currently stands at 2.67. In other words for every 100,000 Soleno Therapeutics shares traded daily on the market, roughly 2670 shares are currently held short.

However Soleno Therapeutics's short interest can also be evaluated against the total number of Soleno Therapeutics shares, or, against the total number of tradable Soleno Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Soleno Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Soleno Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0251% of the tradable shares (for every 100,000 tradable Soleno Therapeutics shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Soleno Therapeutics.

Find out more about how you can short Soleno Therapeutics stock.

Soleno Therapeutics share dividends

We're not expecting Soleno Therapeutics to pay a dividend over the next 12 months.

Have Soleno Therapeutics's shares ever split?

Soleno Therapeutics's shares were split on a 1:5 basis on 5 October 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soleno Therapeutics shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Soleno Therapeutics shares which in turn could have impacted Soleno Therapeutics's share price.

Soleno Therapeutics share price volatility

Over the last 12 months, Soleno Therapeutics's shares have ranged in value from as little as $0.752 up to $3.36. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soleno Therapeutics's is 0.4233. This would suggest that Soleno Therapeutics's shares are less volatile than average (for this exchange).

Soleno Therapeutics overview

Soleno Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases.

Frequently asked questions

What percentage of Soleno Therapeutics is owned by insiders or institutions?
Currently 21.987% of Soleno Therapeutics shares are held by insiders and 37.09% by institutions.
How many people work for Soleno Therapeutics?
Latest data suggests 17 work at Soleno Therapeutics.
When does the fiscal year end for Soleno Therapeutics?
Soleno Therapeutics's fiscal year ends in December.
Where is Soleno Therapeutics based?
Soleno Therapeutics's address is: 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065
What is Soleno Therapeutics's ISIN number?
Soleno Therapeutics's international securities identification number is: US8342032005
What is Soleno Therapeutics's CUSIP number?
Soleno Therapeutics's Committee on Uniform Securities Identification Procedures number is: 14066L105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site